DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023" report has been added to Research and Markets' offering.
The report on global Gastrointestinal Drugs market provides qualitative and quantitative analysis for the period of 2017 to 2023. The report predicts the global Gastrointestinal Drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. The global Gastrointestinal Drugs market was worth USD 46.5 Billion in 2016.
The study on Gastrointestinal Drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.
Scope of the Report:
By Drug Category
- Antineutralizers
- Laxatives and Anti-diarrheal
- Antiemetic
- Anti-inflammatory
By Route of Administration
- Oral
- Parenteral
- Rectal
By Disease Type
- Gastroesophageal Reflux Disorder (GERD)
- Inflammatory Bowel Disease
- Others
By End User
- Hospital Pharmacies
- Retail Pharmacies
- Others
Companies Mentioned
- Abbott Laboratories
- Allergan Plc
- Bayer AG
- AstraZeneca
- Boehringer Ingelheim GmbH
- GlaxoSmithKline Plc
- Janssen Biotech Inc
- Sanofi
- Takeda Pharmaceutical
Key Topics Covered:
1. Preface
2. Executive Summary
3. Global Gastrointestinal Drugs Market Overview
4. Global Gastrointestinal Drugs Market: Snapshots
5. Global Gastrointestinal Drugs by Drug Category (USD Billion) 2017-2023
6. Global Gastrointestinal Drugs Market Analysis, by Route Of Administration (USD Billion) 2017-2023
7. Global Gastrointestinal Drugs Market Analysis, by Disease Type (USD Billion) 2017-2023
8. Global Gastrointestinal Drugs Market Analysis, by End User (USD Billion) 2017-2023
9. Global Gastrointestinal Drugs Market Analysis, by Region (USD Billion) 2017-2023
10. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/rjwdh7/gastrointestinal
